Concepedia

Publication | Open Access

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

DOIFull Paper Access

128

Citations

43

References

2009

Year

David A. Reardon, G. Dresemann, Sophie Taillibert, Mario Campone, Martin J. van den Bent, Paul M. Clément, Erik Blomquist, Laurence Gordower, Henrik Schultz, Jeffrey Raizer,
British Journal of Cancer

Abstract

Imatinib in addition to hydroxyurea was well tolerated among patients with recurrent GBM but did not show clinically meaningful anti-tumour activity.

References

YearCitations

Page 1